Premium Brand STROMUSC Dianabol 50mg/ml For Bodybuilding CAS:72-63-9
Methandrostenolone—more commonly recognized by its trade name Dianabol, or simply Dbol—occupies a singular position in the history of performance enhancement. First synthesized by the pharmaceutical company Ciba in 1958, this compound was famously introduced to the American Olympic weightlifting team by Dr. John Ziegler as a direct response to the dominance of Soviet athletes. Nearly seven decades later, it remains one of the most widely used oral anabolic steroids for rapid mass acquisition, and its injectable variant, particularly the 50mg/ml concentration, has carved out a distinct niche among bodybuilders seeking an alternative delivery route. This article provides an in-depth examination of the premium brand 50mg/ml injectable Dianabol formulation—its chemical identity, pharmacological characteristics, practical applications, dosing protocols, and the critical importance of post-cycle therapy.
Chemical Identity and Mechanism of Action
Methandrostenolone (17β-hydroxy-17α-methylandrosta-1,4-dien-3-one) is a modified derivative of testosterone. The key structural alterations include a 1-2 double bond, which reduces androgenic activity while enhancing the anabolic ratio, and a 17-alpha methyl group, which confers oral bioavailability by resisting first-pass hepatic metabolism. In classic bioassays, Dianabol demonstrates an anabolic rating approximately twice that of testosterone, with an androgenic rating of roughly 60% relative to testosterone. This dissociation between anabolic and androgenic effects is central to its appeal among physique athletes.
A fascinating pharmacological paradox characterizes methandrostenolone: despite exhibiting a relatively low affinity for the androgen receptor in vitro-often less than 5% relative to the reference ligand R1881-its in vivo potency is remarkably high. This discrepancy has been attributed to several factors. Dianabol does not bind meaningfully to sex hormone-binding globulin (SHBG), meaning a far greater proportion of circulating drug remains in its free, biologically active state. Additionally, the compound appears to engage non-genomic signaling pathways, including kinase cascades such as MAPK/ERK, which may operate independently of classical nuclear receptor translocation. The net result is a compound that produces pronounced anabolic effects through mechanisms that extend beyond simple androgen receptor activation.
Injectable vs Oral Delivery: The 50mg/ml Distinction
The vast majority of Dianabol use occurs via oral tablets, typically dosed between 20 and 50 milligrams per day. However, the premium injectable formulation at 50mg/ml introduces several pharmacokinetic and practical differences that merit careful consideration.
The most significant distinction lies in half-life. Oral Dianabol undergoes rapid hepatic metabolism, yielding an active half-life of approximately 3 to 6 hours. This short duration necessitates multiple daily administrations to maintain stable blood concentrations. Injectable Dianabol, by contrast, has been reported to possess a substantially longer half-life-up to approximately 39 hours according to some sources-because the oil-based depot bypasses the immediate first-pass degradation that oral administration imposes. This extended window means that the injectable version can be administered less frequently, potentially every other day or even less, while still sustaining therapeutic blood levels.
From a bioavailability standpoint, the injectable format also offers advantages. Oral Dianabol loses a portion of its active content to gastric degradation and hepatic extraction before reaching systemic circulation. The intramuscular route avoids this loss, delivering the full 50mg dose directly into the bloodstream. Anecdotal reports from experienced users suggest that 30mg of injectable Dianabol may produce effects comparable to 50mg taken orally, reflecting this improved bioavailability.
It is important to note that the 17-alpha methyl group remains present in the injectable formulation. As a result, the compound retains its hepatotoxic potential regardless of the delivery route, and the same precautions regarding liver health apply equally to both forms.
Applications and Bodybuilding Benefits
Dianabol's primary application in bodybuilding is as a "kickstart" compound-a fast-acting oral or injectable used during the initial weeks of a longer cycle while slower-acting injectables such as testosterone enanthate or cypionate gradually reach steady-state concentrations. The rationale is straightforward: testosterone esters typically require two to four weeks to saturate the system, whereas Dianabol begins exerting noticeable effects within days. Users frequently report that scale weight climbs by 4 to 8 kilograms within the first month of a Dianabol cycle, accompanied by dramatic increases in training aggression and muscle fullness.
The benefits extend beyond mere water retention-though that is certainly a component. Methandrostenolone drives nitrogen retention, glycogen storage, and myofibrillar protein synthesis while partially blunting the catabolic effects of cortisol. The result is an environment highly conducive to rapid muscle protein accretion. Research dating back to the 1970s and 1980s documented statistically significant increases in lean body mass, body weight, and muscle size among athletes receiving methandienone compared to placebo. While some of the initial weight gain reflects intracellular water and glycogen, the training stimulus facilitated by the compound-greater strength, endurance, and recovery capacity-translates into genuine myofibrillar hypertrophy over the course of a cycle.
Dosage Guidelines and Cycle Structure
Determining an appropriate dosage requires balancing desired outcomes against the compound's hepatotoxic ceiling. For the injectable 50mg/ml formulation, a conservative starting point for a first-time user might be 25mg (0.5ml) administered every other day, which leverages the extended half-life of the injectable version. Intermediate users with prior experience may find 50mg (1ml) every other day to be a reasonable range. Advanced users occasionally employ higher doses, but the principle of diminishing returns applies sharply here-side effects escalate disproportionately beyond 50mg daily equivalent, while additional anabolic benefit becomes marginal.
A typical Dianabol cycle is remarkably short by anabolic steroid standards. Four to six weeks is the practical ceiling, not merely a suggestion. This brevity is dictated by the 17-alpha alkylated structure, which imposes cumulative hepatic stress that grows more pronounced with each passing week. Extending a Dianabol cycle beyond six weeks at meaningful doses invites elevated liver enzymes, cholestatic jaundice, and potentially more serious hepatic complications. The compound is almost always stacked with a testosterone base-typically 400 to 600mg per week of a long-acting ester-which continues the anabolic momentum after the Dianabol is discontinued.
Half-Life Considerations for the Injectable Variant
The half-life of the 50mg/ml injectable formulation deserves particular attention because it diverges meaningfully from the oral standard. As noted, oral Dianabol clears the system in roughly 3 to 6 hours. The injectable version, however, appears to sustain measurable blood concentrations for considerably longer. One widely cited figure places the half-life of injectable Dianabol at approximately 39 hours. This estimate originates from community discussions rather than peer-reviewed pharmacokinetic studies, and some pharmacologically informed observers caution that dissolving methandrostenolone in oil does not chemically esterify the compound-meaning the active drug may still be released and cleared relatively rapidly once it enters circulation.
Regardless of the precise half-life, the practical implication is clear: injectable Dianabol does not require the twice- or thrice-daily dosing schedule that oral tablets demand. A once-daily or every-other-day injection protocol is generally sufficient to maintain stable blood levels. This simplicity of administration is one of the principal advantages cited by users who prefer the injectable route.
Post-Cycle Therapy: The Non-Negotiable Component
Methandrostenolone suppresses endogenous testosterone production through negative feedback on the hypothalamic-pituitary-gonadal axis. Without intervention, this suppression can persist for weeks or months after the last dose, leaving the user in a catabolic, hypogonadal state that undermines the very gains the cycle was intended to produce. Post-cycle therapy (PCT) is therefore not optional-it is a fundamental component of responsible Dianabol use.
The timing of PCT initiation depends on the clearance rate of the compound used. For oral Dianabol, with its short half-life, PCT may begin within 24 to 48 hours after the final dose. For the injectable 50mg/ml formulation, the extended clearance window-however one interprets the 39-hour half-life figure-suggests a slightly longer wait, perhaps three to five days, to allow the drug to sufficiently leave the system before stimulating the axis. Starting PCT too early, while active androgens remain, simply wastes the serm's effects.
The standard protocol involves selective estrogen receptor modulators (SERMs). Tamoxifen (Nolvadex) at 40mg daily for the first week, reduced to 20mg daily for weeks two through four, is a well-established approach. Clomiphene (Clomid) at 50mg daily for four weeks is an alternative, though some users report more pronounced emotional side effects with Clomid. A combined protocol-Nolvadex 20mg and Clomid 25 to 50mg daily for four weeks-is frequently employed for more aggressive suppression scenarios. Bloodwork to assess luteinizing hormone, follicle-stimulating hormone, and total testosterone should be conducted before, during, and after PCT to confirm that recovery is progressing adequately.
Clinical Data
| Brand | STROMUSC |
|
Trade names |
Dianabol, Methandienone; Methandrostenolone; Methandrolone; Dehydromethyltestosterone; Methylboldenone; Perabol; |
|
CAS |
72-63-9 |
|
Molar mass |
300.442 |
|
Formula |
C20H28O2 |
|
Purity |
Above 98% |
|
Apprarance |
50mg/ml,10ml/bottle |
Any needs, please contact us
Email: Jasonraws106@gmail.com
WhatsApp: +86-15572565525
Telegram: +86-15871669785
Conclusion
The premium brand 50mg/ml injectable Methandrostenolone represents a specialized delivery format for one of bodybuilding's most historically significant compounds. Its extended half-life and improved bioavailability relative to oral tablets offer practical advantages for users who are comfortable with intramuscular administration. The anabolic potency that made Dianabol famous-rapid mass accrual, enhanced strength, and pronounced nitrogen retention-remains fully intact in the injectable form. Yet the fundamental risks are unchanged: hepatotoxicity from the 17-alpha methyl group, estrogenic side effects from aromatization to methylestradiol, and profound suppression of natural testosterone production. The 50mg/ml concentration demands respect in both dosing precision and cycle length discipline. Used within a well-structured protocol that includes a testosterone base, ancillary support for liver and blood pressure, and a properly timed PCT, injectable Dianabol can serve as an effective tool for the experienced bodybuilder. Used without these safeguards, it invites the same adverse outcomes that have shadowed methandrostenolone for nearly seventy years.
Hot Tags: premium brand stromusc dianabol 50mg/ml for bodybuilding cas:72-63-9, China premium brand stromusc dianabol 50mg/ml for bodybuilding cas:72-63-9 manufacturers, suppliers, factory
